Skip to main content
letter
. 2020 Oct 26;134(1):117–119. doi: 10.1097/CM9.0000000000001179

Figure 1.

Figure 1

(A) Summary of a 16-week response to secukinumab. (B) Percentage change between values at baseline and those until 16 weeks. (C) Comparison of DLQI before and after treatment. (D) Comparison of PGA before and after treatment. (E–G) Conditions of one patient with psoriasis after treatment (0–8 weeks). DLQI: Dermatology life quality index; PASI: Psoriasis area and severity index; PGA: Physician's global assessment.